Standard

A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report. / Auvin, Stephane; Bissler, John J.; Cottin, Vincent; Fujimoto, Ayataka; Hofbauer, Guenther F. L.; Jansen, Anna C.; Jozwiak, Sergiusz; Kerecuk, Larissa; Kingswood, J. Christopher; Moavero, Romina; Torra, Roser; Villanueva, Vicente.

In: Orphanet Journal of Rare Diseases, Vol. 14, No. 1, 91, 30.04.2019, p. 91.

Research output: Contribution to journalArticle

Harvard

Auvin, S, Bissler, JJ, Cottin, V, Fujimoto, A, Hofbauer, GFL, Jansen, AC, Jozwiak, S, Kerecuk, L, Kingswood, JC, Moavero, R, Torra, R & Villanueva, V 2019, 'A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report', Orphanet Journal of Rare Diseases, vol. 14, no. 1, 91, pp. 91. https://doi.org/10.1186/s13023-019-1072-y

APA

Auvin, S., Bissler, J. J., Cottin, V., Fujimoto, A., Hofbauer, G. F. L., Jansen, A. C., ... Villanueva, V. (2019). A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report. Orphanet Journal of Rare Diseases, 14(1), 91. [91]. https://doi.org/10.1186/s13023-019-1072-y

Vancouver

Author

Auvin, Stephane ; Bissler, John J. ; Cottin, Vincent ; Fujimoto, Ayataka ; Hofbauer, Guenther F. L. ; Jansen, Anna C. ; Jozwiak, Sergiusz ; Kerecuk, Larissa ; Kingswood, J. Christopher ; Moavero, Romina ; Torra, Roser ; Villanueva, Vicente. / A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report. In: Orphanet Journal of Rare Diseases. 2019 ; Vol. 14, No. 1. pp. 91.

BibTeX

@article{73bb8fb9bcef45acb1ad69001437f52d,
title = "A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report",
abstract = "Background: Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disorder associated with mutations in TSC1 and TSC2 genes, upregulation of mammalian target of rapamycin signaling, and subsequent tumor formation in various organs. Due to the many manifestations of TSC and their potential complications, management requires the expertise of multiple medical disciplines. A multidisciplinary care approach is recommended by consensus guidelines. Use of multidisciplinary teams (MDTs) has been shown to be beneficial in treating other complex diseases, such as cancer. In a lifelong disease such as TSC, an MDT may facilitate the transition from pediatric to adult care. However, little guidance exists in the literature regarding how to organize an MDT in TSC. Methods: To discuss the best approach to assembling an MDT, this project was initiated in October 2017 with a meeting of 12 physicians from various specialties and various countries. Following this first meeting, the experts generated statements on the most important aspects to implement in establishing an MDT for TSC by 3 rounds of selection using a Delphi process via electronic correspondence. Finally, TSC patient advocates reviewed the findings and provided additional insights from a patient perspective. Results: A 3-step roadmap was recommended, starting with identifying a single individual to begin organizing care (Step 1), then establishing a small core team (Step 2), and finally, establishing a larger multi-disciplinary team (Step 3). Because of the multisystemic nature of TSC, the MDT should include specialists such as a neurologist, a neurosurgeon, a nephrologist, a urologist, a pulmonologist, an ophthalmologist, a cardiologist, a dermatologist, a geneticist, and a psychiatrist/psychologist. The MDT should recommend a care plan for each patient based on the individual's needs and in consultation with him/her or his/her family. Some of the most important aspects of an MDT that were agreed upon included identifying a case manager to help coordinate care, providing access to health care professionals of varying specialties, and including a lead physician who takes medical responsibility for patients' overall care. Conclusions: The results of our consensus provide guidance to support the initiation of an MDT in TSC.",
keywords = "Multidisciplinary care, Multidisciplinary team, Tuberous sclerosis complex",
author = "Stephane Auvin and Bissler, {John J.} and Vincent Cottin and Ayataka Fujimoto and Hofbauer, {Guenther F. L.} and Jansen, {Anna C.} and Sergiusz Jozwiak and Larissa Kerecuk and Kingswood, {J. Christopher} and Romina Moavero and Roser Torra and Vicente Villanueva",
year = "2019",
month = "4",
day = "30",
doi = "10.1186/s13023-019-1072-y",
language = "English",
volume = "14",
pages = "91",
journal = "Orphanet Journal of Rare Diseases",
issn = "1750-1172",
publisher = "BioMed Central",
number = "1",

}

RIS

TY - JOUR

T1 - A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report

AU - Auvin, Stephane

AU - Bissler, John J.

AU - Cottin, Vincent

AU - Fujimoto, Ayataka

AU - Hofbauer, Guenther F. L.

AU - Jansen, Anna C.

AU - Jozwiak, Sergiusz

AU - Kerecuk, Larissa

AU - Kingswood, J. Christopher

AU - Moavero, Romina

AU - Torra, Roser

AU - Villanueva, Vicente

PY - 2019/4/30

Y1 - 2019/4/30

N2 - Background: Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disorder associated with mutations in TSC1 and TSC2 genes, upregulation of mammalian target of rapamycin signaling, and subsequent tumor formation in various organs. Due to the many manifestations of TSC and their potential complications, management requires the expertise of multiple medical disciplines. A multidisciplinary care approach is recommended by consensus guidelines. Use of multidisciplinary teams (MDTs) has been shown to be beneficial in treating other complex diseases, such as cancer. In a lifelong disease such as TSC, an MDT may facilitate the transition from pediatric to adult care. However, little guidance exists in the literature regarding how to organize an MDT in TSC. Methods: To discuss the best approach to assembling an MDT, this project was initiated in October 2017 with a meeting of 12 physicians from various specialties and various countries. Following this first meeting, the experts generated statements on the most important aspects to implement in establishing an MDT for TSC by 3 rounds of selection using a Delphi process via electronic correspondence. Finally, TSC patient advocates reviewed the findings and provided additional insights from a patient perspective. Results: A 3-step roadmap was recommended, starting with identifying a single individual to begin organizing care (Step 1), then establishing a small core team (Step 2), and finally, establishing a larger multi-disciplinary team (Step 3). Because of the multisystemic nature of TSC, the MDT should include specialists such as a neurologist, a neurosurgeon, a nephrologist, a urologist, a pulmonologist, an ophthalmologist, a cardiologist, a dermatologist, a geneticist, and a psychiatrist/psychologist. The MDT should recommend a care plan for each patient based on the individual's needs and in consultation with him/her or his/her family. Some of the most important aspects of an MDT that were agreed upon included identifying a case manager to help coordinate care, providing access to health care professionals of varying specialties, and including a lead physician who takes medical responsibility for patients' overall care. Conclusions: The results of our consensus provide guidance to support the initiation of an MDT in TSC.

AB - Background: Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disorder associated with mutations in TSC1 and TSC2 genes, upregulation of mammalian target of rapamycin signaling, and subsequent tumor formation in various organs. Due to the many manifestations of TSC and their potential complications, management requires the expertise of multiple medical disciplines. A multidisciplinary care approach is recommended by consensus guidelines. Use of multidisciplinary teams (MDTs) has been shown to be beneficial in treating other complex diseases, such as cancer. In a lifelong disease such as TSC, an MDT may facilitate the transition from pediatric to adult care. However, little guidance exists in the literature regarding how to organize an MDT in TSC. Methods: To discuss the best approach to assembling an MDT, this project was initiated in October 2017 with a meeting of 12 physicians from various specialties and various countries. Following this first meeting, the experts generated statements on the most important aspects to implement in establishing an MDT for TSC by 3 rounds of selection using a Delphi process via electronic correspondence. Finally, TSC patient advocates reviewed the findings and provided additional insights from a patient perspective. Results: A 3-step roadmap was recommended, starting with identifying a single individual to begin organizing care (Step 1), then establishing a small core team (Step 2), and finally, establishing a larger multi-disciplinary team (Step 3). Because of the multisystemic nature of TSC, the MDT should include specialists such as a neurologist, a neurosurgeon, a nephrologist, a urologist, a pulmonologist, an ophthalmologist, a cardiologist, a dermatologist, a geneticist, and a psychiatrist/psychologist. The MDT should recommend a care plan for each patient based on the individual's needs and in consultation with him/her or his/her family. Some of the most important aspects of an MDT that were agreed upon included identifying a case manager to help coordinate care, providing access to health care professionals of varying specialties, and including a lead physician who takes medical responsibility for patients' overall care. Conclusions: The results of our consensus provide guidance to support the initiation of an MDT in TSC.

KW - Multidisciplinary care

KW - Multidisciplinary team

KW - Tuberous sclerosis complex

UR - http://www.scopus.com/inward/record.url?scp=85065141970&partnerID=8YFLogxK

U2 - 10.1186/s13023-019-1072-y

DO - 10.1186/s13023-019-1072-y

M3 - Article

C2 - 31039793

VL - 14

SP - 91

JO - Orphanet Journal of Rare Diseases

JF - Orphanet Journal of Rare Diseases

SN - 1750-1172

IS - 1

M1 - 91

ER -

ID: 45829771